All In MedTech

Device Trial Radar · NCT05559697

Study Comparing iNPWT Dressing and Devices Affect on Bioburden Levels and Skin Condition After Seven Days

Healthy Human Study on DeRoyal Incisional Dressing With NPWT Compared Against Standard of Care NPWT Incision Dressing to Investigate Bioburden Levels and Skin Condition After Seven Day Period

Last checked: Nov 20, 2026Latest source record: Mar 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

16

Actual

Start

Feb 26, 2024

Primary completion

Mar 7, 2024

Study completion Mar 7, 2024

Sponsor

Lead sponsor
DeRoyal Industries, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Lincoln Memorial University
First posted
Sep 29, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Incisional dressings aim to prevent contamination of an incisional wound and protect against skin irritation. Surgeons use incisional negative pressure wound therapy (iNPWT) to manage incisional wounds. This study compares a new dressing designed for use with iNPWT that aims to improve comfort, tolerability, and dressing survivability over the standard of care for iNPWT. Further, no evidence exists that shows NPWT reduces the bacterial burden on the skin. This study will compare the incidence of skin irritation, dressing damage or lift, and changes in bacteria flora on healthy volunteer skin.

Conditions

  • Skin Reaction to Mechanical, Thermal and Radiation Stimuli
  • Skin Sensitisation

Interventions

  • Sponsor incisional negative pressure wound therapy device and dressingDevice

    A sponsor incisional dressing placed on the knee and connected to a sponsor disposable negative pressure therapy device

  • Standard of Care incisional negative pressure wound therapy systemDevice

    The control incisional negative pressure wound therapy system represents the standard of care system and market leader. It consists of a disposable negative pressure therapy device and incisional dressing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Skin Irritation ScoreTime frame: Day 1 (Baseline) and Day 7

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lincoln Memorial University; Cedar Bluff Campus

    Knoxville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.